Selected article for: "cumulative incidence and hospital admission"
Author: Zuccaro, Valentina; Celsa, Ciro; Sambo, Margherita; Battaglia, Salvatore; Sacchi, Paolo; Biscarini, Simona; Valsecchi, Pietro; Pieri, Teresa Chiara; Gallazzi, Ilaria; Colaneri, Marta; Sachs, Michele; Roda, Silvia; Asperges, Erika; Lupi, Matteo; Di Filippo, Alessandro; Seminari, Elena; Di Matteo, Angela; Novati, Stefano; Maiocchi, Laura; Enea, Marco; Attanasio, Massimo; Cammà, Calogero; Bruno, Raffaele
Title: Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE)
  • Cord-id: bwntb5uc
  • Document date: 2021_1_13
    • ID: bwntb5uc
    Snippet: An accurate prediction of the clinical outcomes of European patients requiring hospitalisation for Coronavirus Disease 2019 (COVID-19) is lacking. The aim of the study is to identify predictors of in-hospital mortality and discharge in a cohort of Lombardy patients with COVID-19. All consecutive hospitalised patients from February 21st to March 30th, 2020, with confirmed COVID-19 from the IRCCS Policlinico San Matteo, Pavia, Lombardy, Italy, were included. In-hospital mortality and discharge wer
    Document: An accurate prediction of the clinical outcomes of European patients requiring hospitalisation for Coronavirus Disease 2019 (COVID-19) is lacking. The aim of the study is to identify predictors of in-hospital mortality and discharge in a cohort of Lombardy patients with COVID-19. All consecutive hospitalised patients from February 21st to March 30th, 2020, with confirmed COVID-19 from the IRCCS Policlinico San Matteo, Pavia, Lombardy, Italy, were included. In-hospital mortality and discharge were evaluated by competing risk analysis. The Fine and Gray model was fitted in order to estimate the effect of covariates on the cumulative incidence functions (CIFs) for in-hospital mortality and discharge. 426 adult patients [median age 68 (IQR 56 to 77 years)] were admitted with confirmed COVID-19 over a 5-week period; 292 (69%) were male. By 21 April 2020, 141 (33%) of these patients had died, 239 (56%) patients had been discharged and 46 (11%) were still hospitalised. Among these 46 patients, updated as of 30 May, 2020, 5 (10.9%) had died, 8 (17.4%) were still in ICU, 12 (26.1%) were transferred to lower intensity care units and 21 (45.7%) were discharged. Regression on the CIFs for in-hospital mortality showed that older age, male sex, number of comorbidities and hospital admission after March 4th were independent risk factors associated with in-hospital mortality. Older age, male sex and number of comorbidities definitively predicted in-hospital mortality in hospitalised patients with COVID-19.

    Search related documents:
    Co phrase search for related documents
    • acute cardiac injury and admission time: 1, 2, 3, 4, 5, 6, 7
    • acute cardiac injury and lopinavir ritonavir: 1, 2, 3, 4
    • acute cardiac injury and lopinavir ritonavir mg: 1
    • acute kidney injury and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8
    • acute kidney injury and admission follow: 1, 2, 3, 4, 5
    • acute kidney injury and admission time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute kidney injury and lombardy region: 1, 2
    • acute kidney injury and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • adaptive innate and admission follow: 1
    • adaptive innate and admission time: 1, 2, 3, 4
    • adaptive innate and lopinavir ritonavir: 1, 2, 3
    • admission follow and lopinavir ritonavir: 1, 2
    • admission time and lombardy cohort: 1
    • admission time and lombardy region: 1
    • admission time and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25